Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Proof of concept, design, and manufacture via 3-D printing of a mesh with bactericidal capacity: Behaviour in vitro and in vivo.

Calero Castro FJ, Yuste Y, Pereira S, Garvín MD, López García MÁ, Padillo FJ, de la Portilla F.

J Tissue Eng Regen Med. 2019 Jul 28. doi: 10.1002/term.2944. [Epub ahead of print]

PMID:
31353843
2.

Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Colomer R, Aranda-López I, Albanell J, García-Caballero T, Ciruelos E, López-García MÁ, Cortés J, Rojo F, Martín M, Palacios-Calvo J.

Clin Transl Oncol. 2018 Aug;20(8):1093-1095. doi: 10.1007/s12094-018-1909-1.

PMID:
29916189
3.

[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

Palacios Calvo J, Albanell J, Rojo F, Ciruelos E, Aranda-López I, Cortés J, García-Caballero T, Martín M, López-García MÁ, Colomer R.

Rev Esp Patol. 2018 Apr - Jun;51(2):97-109. doi: 10.1016/j.patol.2017.12.002. Epub 2018 Mar 14. Spanish.

PMID:
29602380
4.

PACOM: A Versatile Tool for Integrating, Filtering, Visualizing, and Comparing Multiple Large Mass Spectrometry Proteomics Data Sets.

Martínez-Bartolomé S, Medina-Aunon JA, López-García MÁ, González-Tejedo C, Prieto G, Navajas R, Salazar-Donate E, Fernández-Costa C, Yates JR 3rd, Albar JP.

J Proteome Res. 2018 Apr 6;17(4):1547-1558. doi: 10.1021/acs.jproteome.7b00858. Epub 2018 Mar 28.

PMID:
29558135
5.

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Colomer R, Aranda-López I, Albanell J, García-Caballero T, Ciruelos E, López-García MÁ, Cortés J, Rojo F, Martín M, Palacios-Calvo J.

Clin Transl Oncol. 2018 Jul;20(7):815-826. doi: 10.1007/s12094-017-1800-5. Epub 2017 Dec 22. Review. Erratum in: Clin Transl Oncol. 2018 Jun 18;:.

6.

The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

Burgués O, López-García MÁ, Pérez-Míes B, Santiago P, Vieites B, García JF, Peg V.

Clin Transl Oncol. 2018 Mar;20(3):382-391. doi: 10.1007/s12094-017-1725-z. Epub 2017 Aug 9.

PMID:
28795336
7.

Autochthonous Crimean-Congo Hemorrhagic Fever in Spain.

Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, Mora-Rillo M, Astray-Mochales J, Sánchez-Seco MP, Bermejo Lopez E, Menárguez J, Fernández-Cruz A, Sánchez-Artola B, Keough-Delgado E, Ramírez de Arellano E, Lasala F, Milla J, Fraile JL, Ordobás Gavín M, Martinez de la Gándara A, López Perez L, Diaz-Diaz D, López-García MA, Delgado-Jimenez P, Martín-Quirós A, Trigo E, Figueira JC, Manzanares J, Rodriguez-Baena E, Garcia-Comas L, Rodríguez-Fraga O, García-Arenzana N, Fernández-Díaz MV, Cornejo VM, Emmerich P, Schmidt-Chanasit J, Arribas JR; Crimean Congo Hemorrhagic Fever@Madrid Working Group.

N Engl J Med. 2017 Jul 13;377(2):154-161. doi: 10.1056/NEJMoa1615162.

8.

Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.

López-García MA, Feria-Romero IA, Serrano H, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C, Grijalva I, Escalante-Santiago D, Orozco-Suarez S.

Pharmacol Rep. 2017 Jun;69(3):504-511. doi: 10.1016/j.pharep.2017.01.007. Epub 2017 Jan 19.

PMID:
28343093
9.

Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-Guiu X, Palacios J.

Mod Pathol. 2016 Dec;29(12):1594. doi: 10.1038/modpathol.2016.184. No abstract available.

10.

Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther O, Soslow RA, Matias-Guiu X, Palacios J.

Mod Pathol. 2016 Nov;29(11):1390-1398. doi: 10.1038/modpathol.2016.132. Epub 2016 Aug 5. Erratum in: Mod Pathol. 2016 Dec;29(12):1594.

11.

RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.

Lemetre C, Vieites B, Ng CK, Piscuoglio S, Schultheis AM, Marchiò C, Murali R, Lopez-García MA, Palacios JC, Jungbluth AA, Terracciano LM, Reis-Filho JS, Weigelt B.

Eur J Cancer. 2016 Sep;64:149-58. doi: 10.1016/j.ejca.2016.05.028. Epub 2016 Jul 14.

12.

CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy.

Vieites B, López-García MÁ, Castilla C, Hernández MJ, Biscuola M, Alfaro L, Atienza MR, Castilla MÁ, Palacios J.

Histopathology. 2016 Aug;69(2):239-49. doi: 10.1111/his.12924. Epub 2016 Feb 25.

PMID:
26708058
13.

A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.

Romero-Pérez L, Garcia-Sanz P, Mota A, Leskelä S, Hergueta-Redondo M, Díaz-Martín J, López-García MA, Castilla MA, Martínez-Ramírez A, Soslow RA, Matias-Guiu X, Moreno-Bueno G, Palacios J.

Mod Pathol. 2015 Nov;28(11):1492-503. doi: 10.1038/modpathol.2015.102. Epub 2015 Sep 18.

14.

Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer.

Díaz-Martín J, López-García MÁ, Romero-Pérez L, Atienza-Amores MR, Pecero ML, Castilla MÁ, Biscuola M, Santón A, Palacios J.

Endocr Relat Cancer. 2015 Jun;22(3):443-54. doi: 10.1530/ERC-14-0456. Epub 2015 Apr 13.

PMID:
25870251
15.

MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures.

Escalante-Santiago D, Feria-Romero IA, Ribas-Aparicio RM, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C, Grijalva-Otero I, López-García MA, Orozco-Suárez S.

Front Neurol. 2014 Oct 9;5:184. doi: 10.3389/fneur.2014.00184. eCollection 2014.

16.

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry.

Santacana M, Maiques O, Valls J, Gatius S, Abó AI, López-García MÁ, Mota A, Reventós J, Moreno-Bueno G, Palacios J, Bartosch C, Dolcet X, Matias-Guiu X.

Hum Pathol. 2014 Dec;45(12):2394-403. doi: 10.1016/j.humpath.2014.06.031. Epub 2014 Aug 23.

PMID:
25282036
17.

Genetic polymorphisms associated with antiepileptic metabolism.

Lopez-Garcia MA, Feria-Romero IA, Fernando-Serrano H, Escalante-Santiago D, Grijalva I, Orozco-Suarez S.

Front Biosci (Elite Ed). 2014 Jun 1;6:377-86. Review.

PMID:
24896213
18.

VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.

Castilla MÁ, López-García MÁ, Atienza MR, Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L, Benítez J, Calcabrini A, Palacios J.

Endocr Relat Cancer. 2014 Aug;21(4):587-99. doi: 10.1530/ERC-13-0485. Epub 2014 Jun 2.

PMID:
24891455
19.

Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.

Melchor L, Molyneux G, Mackay A, Magnay FA, Atienza M, Kendrick H, Nava-Rodrigues D, López-García MÁ, Milanezi F, Greenow K, Robertson D, Palacios J, Reis-Filho JS, Smalley MJ.

J Pathol. 2014 Jun;233(2):124-37. doi: 10.1002/path.4345.

PMID:
24615332
20.

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.

Amaral AT, Manara MC, Berghuis D, Ordóñez JL, Biscuola M, Lopez-García MA, Osuna D, Lucarelli E, Alviano F, Lankester A, Scotlandi K, de Álava E.

PLoS One. 2014 Feb 3;9(2):e85814. doi: 10.1371/journal.pone.0085814. eCollection 2014. Erratum in: PLoS One.2014;9(4):e94455.

21.

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.

Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

Mod Pathol. 2013 Nov;26(11):1514-24. doi: 10.1038/modpathol.2013.93. Epub 2013 Jun 7.

22.

MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.

Perez M, Praena-Fernandez JM, Felipe-Abrio B, Lopez-Garcia MA, Lucena-Cacace A, Garcia A, Lleonart M, Roncador G, Marin JJ, Carnero A.

PLoS One. 2013;8(2):e56169. doi: 10.1371/journal.pone.0056169. Epub 2013 Feb 13.

23.

Enhanced chemopreventive activity of hydroxytyrosol on HL60 and HL60R cells by chemical conversion into thio derivatives.

Sepporta MV, López-García MÁ, Fabiani R, Maya I, Fernández-Bolaños JG.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):790-8. doi: 10.1016/j.ejps.2012.12.028. Epub 2013 Jan 9.

PMID:
23313620
24.

Oncogene alterations in endometrial carcinosarcomas.

Biscuola M, Van de Vijver K, Castilla MÁ, Romero-Pérez L, López-García MÁ, Díaz-Martín J, Matias-Guiu X, Oliva E, Palacios Calvo J.

Hum Pathol. 2013 May;44(5):852-9. doi: 10.1016/j.humpath.2012.07.027. Epub 2012 Nov 28.

PMID:
23199529
25.

MicroRNA-200 family modulation in distinct breast cancer phenotypes.

Castilla MÁ, Díaz-Martín J, Sarrió D, Romero-Pérez L, López-García MÁ, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J.

PLoS One. 2012;7(10):e47709. doi: 10.1371/journal.pone.0047709. Epub 2012 Oct 24.

26.

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Romero-Pérez L, Castilla MÁ, López-García MÁ, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J.

Hum Pathol. 2013 Feb;44(2):244-54. doi: 10.1016/j.humpath.2012.05.013. Epub 2012 Sep 10.

PMID:
22974476
27.

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.

Wetterskog D, Lopez-Garcia MA, Lambros MB, A'Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A, Shiu KK, Orr N, Shousha S, Gatalica Z, Mackay A, Palacios J, Reis-Filho JS, Weigelt B.

J Pathol. 2012 Jan;226(1):84-96. doi: 10.1002/path.2974. Epub 2011 Oct 20.

PMID:
22015727
28.

The ProteoRed MIAPE web toolkit: a user-friendly framework to connect and share proteomics standards.

Medina-Aunon JA, Martínez-Bartolomé S, López-García MA, Salazar E, Navajas R, Jones AR, Paradela A, Albar JP.

Mol Cell Proteomics. 2011 Oct;10(10):M111.008334. doi: 10.1074/mcp.M111.008334.

29.

Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.

Geyer FC, de Biase D, Lambros MB, Ragazzi M, Lopez-Garcia MA, Natrajan R, Mackay A, Kurelac I, Gasparre G, Ashworth A, Eusebi V, Reis-Filho JS, Tallini G.

Breast Cancer Res Treat. 2012 Feb;132(1):15-28. doi: 10.1007/s10549-011-1504-4. Epub 2011 Apr 21.

PMID:
21509527
30.

Pathologic and molecular features of uterine carcinosarcomas.

Lopez-Garcia MA, Palacios J.

Semin Diagn Pathol. 2010 Nov;27(4):274-86. Review.

PMID:
21309261
31.

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.

Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J, Matías-Guiu X, Cano A, Oliva E, Palacios J.

J Pathol. 2011 Jan;223(1):72-80. doi: 10.1002/path.2802. Epub 2010 Oct 29.

PMID:
21125666
32.

Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.

Abdel-Fatah TM, Powe DG, Ball G, Lopez-Garcia MA, Habashy HO, Green AR, Reis-Filho JS, Ellis IO.

J Pathol. 2010 Dec;222(4):388-99. doi: 10.1002/path.2775.

PMID:
20922713
33.

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.

Dedes KJ, Natrajan R, Lambros MB, Geyer FC, Lopez-Garcia MA, Savage K, Jones RL, Reis-Filho JS.

Eur J Cancer. 2011 Jan;47(1):138-50. doi: 10.1016/j.ejca.2010.08.007. Epub 2010 Sep 9.

PMID:
20832293
34.

Stereocontrolled synthesis of 2-substituted-1,3-azasilaheterocycles.

Hernández D, Nielsen L, Lindsay KB, López-García MA, Bjerglund K, Skrydstrup T.

Org Lett. 2010 Aug 6;12(15):3528-31. doi: 10.1021/ol101379t.

PMID:
20670017
35.

Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.

Lopez-Garcia MA, Geyer FC, Natrajan R, Kreike B, Mackay A, Grigoriadis A, Reis-Filho JS, Weigelt B.

J Pathol. 2010 Sep;222(1):64-75. doi: 10.1002/path.2743.

PMID:
20593406
36.

PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study.

Lambros MB, Natrajan R, Geyer FC, Lopez-Garcia MA, Dedes KJ, Savage K, Lacroix-Triki M, Jones RL, Lord CJ, Linardopoulos S, Ashworth A, Reis-Filho JS.

Mod Pathol. 2010 Oct;23(10):1334-45. doi: 10.1038/modpathol.2010.121. Epub 2010 Jun 11.

37.

Breast cancer precursors revisited: molecular features and progression pathways.

Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS.

Histopathology. 2010 Aug;57(2):171-92. doi: 10.1111/j.1365-2559.2010.03568.x. Epub 2010 May 24. Review.

PMID:
20500230
38.

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.

Dedes KJ, Lopez-Garcia MA, Geyer FC, Lambros MB, Savage K, Vatcheva R, Wilkerson P, Wetterskog D, Lacroix-Triki M, Natrajan R, Reis-Filho JS.

Breast Cancer Res Treat. 2010 Dec;124(3):653-66. doi: 10.1007/s10549-010-0816-0. Epub 2010 Mar 6.

PMID:
20213079
39.

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

Turner N, Pearson A, Sharpe R, Lambros M, Geyer F, Lopez-Garcia MA, Natrajan R, Marchio C, Iorns E, Mackay A, Gillett C, Grigoriadis A, Tutt A, Reis-Filho JS, Ashworth A.

Cancer Res. 2010 Mar 1;70(5):2085-94. doi: 10.1158/0008-5472.CAN-09-3746. Epub 2010 Feb 23.

40.

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.

Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW, Lopez-Garcia MA, Green AR, Reis-Filho JS, Ellis IO.

J Pathol. 2010 Mar;220(4):419-34. doi: 10.1002/path.2663.

PMID:
20044801
41.

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K, Kreike B, Reis-Filho JS.

J Pathol. 2010 Jan;220(1):45-57. doi: 10.1002/path.2629.

PMID:
19877120
42.

Genetic characterization of breast cancer and implications for clinical management.

Geyer FC, Lopez-Garcia MA, Lambros MB, Reis-Filho JS.

J Cell Mol Med. 2009 Oct;13(10):4090-103. doi: 10.1111/j.1582-4934.2009.00906.x. Epub 2009 Sep 14. Review.

43.

Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.

Geyer JT, López-García MA, Sánchez-Estevez C, Sarrió D, Moreno-Bueno G, Franceschetti I, Palacios J, Oliva E.

Am J Surg Pathol. 2009 Aug;33(8):1157-63. doi: 10.1097/PAS.0b013e3181a902e1.

PMID:
19542870
44.

Wilms' tumour: a complex enigma to decipher.

Robles-Frías MJ, Biscuola M, Castilla M, López-García MA, Sánchez-Gallego F, Palacios J.

Clin Transl Oncol. 2008 Aug;10(8):457-61. Review.

PMID:
18667375
45.

The molecular pathology of hereditary breast cancer.

Palacios J, Robles-Frías MJ, Castilla MA, López-García MA, Benítez J.

Pathobiology. 2008;75(2):85-94. doi: 10.1159/000123846. Epub 2008 Jun 10. Review.

46.

Mitochondrial genome polymorphisms associated with longissimus muscle composition in Iberian pigs.

Fernández AI, Alves E, Fernández A, de Pedro E, López-García MA, Ovilo C, Rodríguez MC, Silió L.

J Anim Sci. 2008 Jun;86(6):1283-90. doi: 10.2527/jas.2007-0568. Epub 2008 Mar 14.

PMID:
18344306
47.

[Current value of clinical autopsy in patients with HIV infection].

Salinas-Martín MV, López-García MA, Fernández-Alonso J.

Enferm Infecc Microbiol Clin. 2007 Apr;25(4):291-2. Spanish. No abstract available.

PMID:
17386228
48.

[Cystic ureteritis in a kidney transplantation candidate].

Argüelles Salido E, Rodríguez Corchero J, López García MA, Pérez Espejo MP, Campoy Martínez P, Pena Outeiriño JM.

Actas Urol Esp. 2005 Feb;29(2):226-9. Spanish.

PMID:
15881924

Supplemental Content

Loading ...
Support Center